z-logo
Premium
Infectious diseases pre‐transplant evaluation improves vaccination rates for liver transplant candidates
Author(s) -
Pineda Erika May Z.,
Spinner Michael L.,
Pallotta Andrea,
Koval Christine,
Bollinger Jessica
Publication year - 2019
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/tid.13160
Subject(s) - medicine , vaccination , liver transplantation , intensive care medicine , immunology , transplantation
Immunization rates in pre‐liver transplant patients have been historically below rates for immunocompetent patients. At Cleveland Clinic, an infectious diseases (ID) consult is required for all patients during the liver transplant evaluation and may beneficially impact vaccination rates. The goal of this study was to evaluate pre‐transplant vaccination rates in pre‐liver transplant candidates. This single‐center, retrospective chart review included adults transplanted between January 1, 2013, and December 31, 2016. Prior to transplant, rates of vaccination and/or documented seropositivity were 35% for hepatitis B vaccine, 92% for hepatitis A vaccine, 57% for pneumococcal conjugate vaccine, 62% for pneumococcal polysaccharide vaccine, and 77% for influenza vaccine. Vaccination rates were higher than to previously reported. Rates were also higher for several vaccines compared to transplant candidates for other organs without ID consult. With ongoing ID consult requirements for liver transplant candidates, combined with standardization of vaccine recommendations via technology, and increased multi‐disciplinary collaboration, vaccination rates should improve further.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here